Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03398902 · ClinicalTrials.gov registry record · NA
Personalizing Sleep Interventions to Prevent Type 2 Diabetes in Community Dwelling Adults With Pre-Diabetes
A NA study, sponsored by New York University.
- Completed
- Registry status
- NA
- Development phase
- 393
- Enrollment target
NCT03398902 is a NA study that has completed, run by New York University. The registered enrollment target is 393 participants.
The verdict
NCT03398902, a NA study, has completed, sponsored by New York University.
- COMPLETED
- Registry status
- NA
- Development phase
- 393 participants
- Enrollment target
Study Summary
This study will use continuous glucose monitoring and actigraphy to examine whether a personalized, daily sleep extension intervention improves glucose regulation for community dwelling, sleep-restricted adults with pre-diabetes. The randomized controlled trial will include 150 adults with pre-diabetes. Sleep extension and habitual sleep groups will complete daily sleep diaries and participate in a weekly 15-minute telephone call or videoconference meeting with a member of the study team (8 sessions total). Data collection will be at 2 time points: pre-randomization and post-intervention (completion of the 8-week intervention). Changes in the percent time glucose is ≥ 140mg/dL at baseline and post-intervention will be established and compared across the sleep extension and habitual sleep arms.
Interventions
- BEHAVIORAL Sleep extension
- OTHER Habitual sleep
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 393 participants |
| Start Date | 2021-03-15 |
| Est. Completion | 2023-09-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03398902
The ClinicalTrials.gov registry entry for NCT03398902 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 393 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York University, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sleep extension is the first listed.
NCT03398902 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03398902 about?
NCT03398902 is a clinical study titled "Personalizing Sleep Interventions to Prevent Type 2 Diabetes in Community Dwelling Adults With Pre-Diabetes". This study will use continuous glucose monitoring and actigraphy to examine whether a personalized, daily sleep extension intervention improves glucose regulation for community dwelling, sleep-restricted adults with pre-diabetes. The randomized controlled trial will include 150 adults with pre-diabe...
What is the current status of trial NCT03398902?
This trial is currently completed. It is a NA study. The enrollment target is 393 participants. The study started on 2021-03-15. Estimated completion is 2023-09-18.
What interventions are being tested in trial NCT03398902?
The interventions under investigation include: Sleep extension (BEHAVIORAL), Habitual sleep (OTHER).
Who is sponsoring clinical trial NCT03398902?
This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.